Abstract Purpose of Review Multiple sclerosis (MS) is an autoimmune disorder of the central
nervous system that can lead to severe physical, cognitive, and neurological deficits that …

Abstract Purpose of review Multiple Sclerosis (MS) is a chronic autoimmune disease with no
curative treatment available. While recent years have ushered in many effective new …

Chronic pain is defined as any consistent pain lasting more than 12 weeks; chronic pain
afflicts 25% of the world's population. The most common form of chronic pain is chronic …

About half of patients with multiple sclerosis (MS) report pain; treatment for pain alone
accounts for nearly 30% of the total use of medications for the management of all MS-related …

Introduction The prevalence of pain in Multiple Sclerosis (MS) is estimated to be between 29-
86% depending on various stages of the disease. According to a recent mechanism-based …

Pain is common in patients with multiple sclerosis (MS), but estimates of its prevalence have
varied widely. The literature describing pain in MS patients spans four decades and has …

Pain is a common symptom in multiple sclerosis (MS) and has recently been estimated to be
experienced by up to 75% of patients. Pain can be present at any point in the course of the …

Pain is an important and frequent symptom in multiple sclerosis (MS), which leads to a low
quality of life, increased disability level, and lack of employment and mental health …

Background Both chronic and acute pain have been cited as the most common symptoms
amongst patients with multiple sclerosis (MS), with recent prevalence estimates as high as …

Previous studies have reported variable prevalence of pain in multiple sclerosis (MS) and
have not documented the impact of pain on daily living. In this consecutive series, we report …